P2.02 Second-line Afatinib vs Erlotinib for Advanced Lung Squamous Cell Carcinoma: Final Analysis of the Phase 3 LUX-Lung 8 Trial
Articles > Article · 2019
Authors: G.D. Goss, M. Cobo, S. Lu, K. Syrigos, K.H. Lee, Erdem GÖKER, V. Georgoulias, W. Li, D. Isla, A. Morabito, Y.J. Min, A. Ardizzoni, H. Jian, Y. Yu, S. Bender, A. Cseh, E. Felip
Journal of Thoracic Oncology, International, WoS, 2019, vol 14, pp S1185-S1185